类风湿关节炎缓解定义:对患者重要吗?多维缓解标准与患者报告结局的比较
横断面研究纳入605例DAS28(CRP)<2.6的RA患者,评估多维缓解(MDR)及其组分与患者报告结局的关系。仅35%达到MDR,且MDR与最佳(最低)PRO评分相关。MDR可能代表更接近正常状态,或为新的治疗目标。
要点
- DAS28缓解患者中仅35%达到多维缓解(MDR)。
- MDR与最佳(最低)患者报告结局评分相关。
- 已建立RA接受多种cs-DMARDs者MDR率较低。
核心结论
- MDR在DAS28缓解患者中约占三分之一,且与更好的患者报告结局相关。
- MDR可能是一种新的最佳治疗目标,尤其从患者角度。
研究设计与样本
- 横断面研究,从炎症性关节炎登记中选取605例DAS28(CRP)<2.6的RA患者。
- 收集人口学、临床和PRO数据,并测量超声能量多普勒滑膜炎(n=364)和T细胞亚群(n=297)。
主要发现
- 仅53%(321/605)达到临床参数缓解,失败主要因CRP升高(52%)、TJC>1(37%)或SJC>1(16%)。
- 211/364(58%)达到超声缓解,193/297(65%)达到T细胞缓解。
- 231例有完整数据,仅35%达到MDR,且MDR与最佳(最低)PRO评分相关(所有P≤0.05 vs 非MDR)。
- MDR率在早期和已建立RA使用b-DMARDs者中相似,但在已建立RA接受多种cs-DMARDs者中较低(P=0.011)。
关键数值与推荐
- 临床缓解定义:TJC、SJC和CRP均≤1。
- 超声缓解定义:总能量多普勒=0。
- T细胞缓解定义:阳性标准化naïve T细胞频率。
- MDR定义:同时达到上述三个维度。
临床怎么用
- 在DAS28缓解的RA患者中,可进一步评估多维缓解以识别更接近正常状态的患者。
- MDR与更好的患者报告结局相关,可作为以患者为中心的治疗目标参考。
局限性
- 横断面设计,无法确立因果或纵向预测价值。
- 部分患者缺失超声或T细胞数据,完整数据仅231例。
- MDR的临床效用需进一步纵向研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In a cross-sectional study, we evaluated the prevalence of 'multi-dimensional remission' (MDR) and its component parameters, assessed using objective measures in a cohort of RA patients in treatment-induced DAS28-remission, and their relationship with patient-reported outcome measures. We sought to confirm the feasibility and face validity of the MDR construct, providing a platform for future longitudinal studies in which its clinical utility might be further established. METHODS: 605 patients were selected from an inflammatory arthritis register using DAS28(CRP)<2.6. Demographic, clinical and patients reported outcomes (PRO) data were collected. Ultrasound power doppler synovitis (n = 364) and T-cell subsets (n = 297) were also measured. Remission using clinical parameters was defined as: tender and swollen joint count (TJC/SJC) and CRP all ⩽1; ultrasound remission: total power doppler = 0 and T cell remission: positive normalized naïve T-cell frequency. MDR was defined as the achievement of all three dimensions. RESULTS: Overall, only 53% (321/605) of the patients achieved clinical parameters, failures being mainly due to raised CRP (52%), TJC (28)>1 (37%) or SJC (28)>1 (16%). 211/364 (58%) of patients achieved ultrasound remission and 193/297 (65%) patients showed T-cell remission. Complete data were available for 231 patients. MDR was observed in only 35% and was associated with the best (lower) PRO scores (all P ⩽ 0.05 vs non-MDR) when compared with the other definitions of remission assessed. The MDR rate was similar in early and established RA patients on b-DMARDs; however, it was lower in established RA patients who received multiple cs-DMARDs (P = 0.011). CONCLUSIONS: In this study, MDR, which may represent a state closer to normality, was found to occur in about a third of DAS28-remission patients and was associated with better patient-reported outcome measures. MDR could be a novel optimal treatment target, notably from a patient's perspective. The relevance of these findings needs further assessment.
引用
- Gul HL, Eugenio G, Rabin T, et al. Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes. Rheumatology (Oxford). 2020. PMID: 31424522. doi:10.1093/rheumatology/kez330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。